Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Bioxyne Limited ( (AU:BXN) ).
Bioxyne Limited has announced the quotation of 18 million ordinary fully paid securities on the Australian Securities Exchange (ASX) as of October 27, 2025. This move, part of an employee incentive scheme, is expected to enhance the company’s market presence and potentially increase shareholder value by expanding its capital base.
More about Bioxyne Limited
Bioxyne Limited operates in the biotechnology industry, focusing on the development and commercialization of health and wellness products. The company is known for its innovative solutions in probiotics and immune health, targeting both domestic and international markets.
Average Trading Volume: 4,309,804
Technical Sentiment Signal: Buy
Current Market Cap: A$91.22M
See more insights into BXN stock on TipRanks’ Stock Analysis page.